Form 4: Director Maggie Yuen Acquires AtriCure Shares

Director Maggie Yuen acquired 6,144 shares of AtriCure, Inc. common stock through a Restricted Stock Award.

Summary

• Director Maggie Yuen acquired 6,144 shares of AtriCure, Inc. common stock on May 18, 2026.
• These shares were acquired under a Restricted Stock Award granted as part of the AtriCure, Inc. 2023 Stock Incentive Plan.
• The acquired shares are subject to vesting upon the one-year anniversary of the grant date.
• Following this transaction, Ms. Yuen beneficially owns 17,515 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard stock award to a director rather than a discretionary purchase or sale of shares.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition is part of a formal stock incentive plan, indicating a structured approach to executive compensation and alignment with shareholder interests.

Future Outlook

The acquired shares will vest upon the one-year anniversary of the grant date, indicating a future event tied to continued service or performance.

Industry Context

StockSavvy.ai notes that insider stock awards are a common practice in the medical device industry to attract and retain talent, aligning management's interests with long-term company growth.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but it does not represent a new investment of personal capital.
• Employees: The stock incentive plan highlights the company's strategy for employee compensation and retention.
• Management: Reinforces the alignment of director compensation with company performance through equity awards.

Next Steps

• Vesting of the acquired shares upon the one-year anniversary of the grant date.

Key Dates

Keywords

AtriCure, ATRC, Form 4, Insider Trading, Restricted Stock Award, Stock Incentive Plan, Director, Beneficial Ownership